Axsome’s depression treatment fails to meet main goal of late-stage study

(Reuters) -Axsome Therapeutics said on Tuesday its experimental drug to treat major depressive disorder failed to meet the main goal of a late-stage study.

(Reporting by Mariam Sunny in Bengaluru; Editing by Leroy Leo)